Learn More
Invitrogen™ Human SRCAP (aa 2555-2686) Control Fragment Recombinant Protein
Recombinant Protein
Marca: Invitrogen™ RP89301
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (62%), Rat (62%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56012 (PA5-56012. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.

Especificaciones
Q6ZRS2 | |
Blocking Assay, Control | |
10847 | |
100 μL | |
B930091H02Rik; D030022P06Rik; domino homolog 2; DOMO1; EAF1; F630004O05Rik; FLHS; FLJ44499; helicase SRCAP; KIAA0309; RGD1565642; Snf2-related CBP activator; Snf2-related CBP activator protein; Snf2-related CREBBP activator protein; SRCAP; Swi2/Snf2-related ATPase homolog, domino homolog 1; SWR1 | |
SRCAP | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human SRCAP (aa 2555-2686) Control Fragment | |
RUO | |
SRCAP | |
Unconjugated | |
Recombinant | |
AQALASPESLELASVASSETSSLSLVPPKDLLPVAVEILPVSEKNLSLTPSAPSLTLEAGSIPNGQEQEAPDSAEGTTLTVLPEGEELPLCVSESNGLELPPSAASDEPLQEPLEADRTSEELTEAKTPTSS | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.